Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroko Nogi

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Breast Cancer (Tokyo, Japan)|November 20, 2008
Mammary ductoscopy: current issues and perspectivesKen Uchida, Hisaki Fukushima, Yasuo Toriumi, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|October 29, 2011
Chest wall reconstruction using Gore-Tex® dual meshTadashi Akiba, Hideki Marushima, Hiroko Nogi, et al.
Breast Cancer (Tokyo, Japan)|April 24, 2009
Malignant neoplasm in the axilla of a male: suspected primary carcinoma of an accessory mammary glandHiroshi Takeyama, Hiroyuki Takahashi, Isao Tabei, et al.
Oncology Reports|January 17, 2009
EGFR as paradoxical predictor of chemosensitivity and outcome among triple-negative breast cancerHiroko Nogi, Tadashi Kobayashi, Masafumi Suzuki, et al.
Anticancer Research|September 30, 2024
Thyroid Cancer With Autocrine Sialyl-fibronectin Depletion Has a Poor Prognosis due to EMT ProgressionRyo Miyake, Hiroshi Takeyama, Yoshinobu Manome, et al.
Cancer Chemotherapy and Pharmacology|June 11, 2005
The angiogenesis inhibitor NM-3 is active against human NSCLC xenografts alone and in combination with docetaxelNaoki Agata, Hiroko Nogi, Michael Bamberg, et al.
International Journal of Clinical Oncology|August 16, 2008
The predictive value of PgR and HER-2 for response to primary systemic chemotherapy in inflammatory breast cancerHiroko Nogi, Tadashi Kobayashi, Isao Tabei, et al.
Scientific Reports|September 19, 2019
Clinical implications of drug-screening assay for recurrent metastatic hormone receptor-positive, human epidermal receptor 2-negative breast cancer using conditionally reprogrammed cellsRei Mimoto, Satomi Yogosawa, Hiroki Saijo, et al.
Surgery Today|December 23, 2006
Primary rhabdomyosarcoma of the breast in a 13-year-old girl: report of a caseHiroko Nogi, Tadashi Kobayashi, Kazumi Kawase, et al.
Surgical Case Reports|May 17, 2017
Primary ectopic breast cancer of the vulva, treated with local excision of the vulva and sentinel lymph node biopsy: a case reportTakayuki Ishigaki, Yasuo Toriumi, Ryouko Nosaka, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Breast Cancer (Tokyo, Japan)|November 20, 2008
Mammary ductoscopy: current issues and perspectivesKen Uchida, Hisaki Fukushima, Yasuo Toriumi, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|October 29, 2011
Chest wall reconstruction using Gore-Tex® dual meshTadashi Akiba, Hideki Marushima, Hiroko Nogi, et al.
Breast Cancer (Tokyo, Japan)|April 24, 2009
Malignant neoplasm in the axilla of a male: suspected primary carcinoma of an accessory mammary glandHiroshi Takeyama, Hiroyuki Takahashi, Isao Tabei, et al.
Oncology Reports|January 17, 2009
EGFR as paradoxical predictor of chemosensitivity and outcome among triple-negative breast cancerHiroko Nogi, Tadashi Kobayashi, Masafumi Suzuki, et al.
Anticancer Research|September 30, 2024
Thyroid Cancer With Autocrine Sialyl-fibronectin Depletion Has a Poor Prognosis due to EMT ProgressionRyo Miyake, Hiroshi Takeyama, Yoshinobu Manome, et al.
Cancer Chemotherapy and Pharmacology|June 11, 2005
The angiogenesis inhibitor NM-3 is active against human NSCLC xenografts alone and in combination with docetaxelNaoki Agata, Hiroko Nogi, Michael Bamberg, et al.
International Journal of Clinical Oncology|August 16, 2008
The predictive value of PgR and HER-2 for response to primary systemic chemotherapy in inflammatory breast cancerHiroko Nogi, Tadashi Kobayashi, Isao Tabei, et al.
Scientific Reports|September 19, 2019
Clinical implications of drug-screening assay for recurrent metastatic hormone receptor-positive, human epidermal receptor 2-negative breast cancer using conditionally reprogrammed cellsRei Mimoto, Satomi Yogosawa, Hiroki Saijo, et al.
Surgery Today|December 23, 2006
Primary rhabdomyosarcoma of the breast in a 13-year-old girl: report of a caseHiroko Nogi, Tadashi Kobayashi, Kazumi Kawase, et al.
Surgical Case Reports|May 17, 2017
Primary ectopic breast cancer of the vulva, treated with local excision of the vulva and sentinel lymph node biopsy: a case reportTakayuki Ishigaki, Yasuo Toriumi, Ryouko Nosaka, et al.
Pageof 5